Macrophage-inhibitory cytokine-1 (mic-1) in differential diagnosis of dyspnea-A pilot study

Clinical Biochemistry

Volumn 42, Issue 13-14, 2009, Pages 1347-1351

  Stejskal, David ^a,b   Karpíšek, Michal ^d   Humeňanská, Viera ^e   Lačňák, Bořek ^c   Švesták, Marek ^a  

^a Central Moravian Hospital County   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c Hospital Krnov   (Czech Republic)

^d UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^e Gnosis sro   (Slovakia)

Author keywords

Dyspnea; ELISA; Heart failure; MIC 1

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIDIABETIC AGENT; GROWTH DIFFERENTIATION FACTOR 15; GUANYLIN;

AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE MARKER; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MYOCARDIAL DISEASE; PILOT STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; VALVULAR HEART DISEASE;

EID: 69249206575     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.03.022     Document Type: Article

References (8)

1. Bootcov M.R., Bauskin A.R., Valenzuela S., et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-3 superfamily. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11514-11519
2. Paralkar V.M., Vail A.L., Grasser W.A., et al. Cloning and characterization of a novel member of the transforming growth factor-h/bone morphogenetic protein family. J. Biol. Chem. 273 (1998) 13760-13767
3. Kempf T., Eden M., Strelau J., Naguib M., Willenbockel C., Tongers J., Heineke J., Kotlarz D., Xu J., Molkentin J.D., Niessen H.W., Drexler H., and Wollert K.C. The transforming growth factor-3 superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ. Res. 98 (2006) 351-360
4. Wolkery K.C., Kempf T., Peter T., Olofsson S., James S., Johnston N., Lindahl B., Horn Wichmann R., Brabant G., Simoons M.L., Armstrong P.W., Califf R.M., Drexler H., and Wallentin L. Prognostic value of growth-differentiation factor-15 in patients with non-st-elevation acute coronary syndrome. Circulation 115 (2007) 962-971
5. Spinar J., and Vitovec K. Radiologic changes in chronic heart failure. Cor et Vasa 34 (1992) 88-99
6. Lankeit M., Kempf T., Dellas C., Cuny M., Tapken H., Peter T., Olschewski M., Konstantinides S., and Wollert K.C. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am. J. Respir. Crit. Care Med. 177 (2008) 1018-1025
7. Kempf T., von Haehling S., Peter T., Allhoff T., Cicoira M., Doehner W., Ponikowski P., Filippatos G.S., Rozentryt P., Drexler H., Anker S.D., and Wollert K.C. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J. Am. Coll. Cardiol. 50 (2007) 1061-1063
8. Björklund E., Olofsson S., Lindahl B., Allhoff T., Peter T., Tongers J., Wollert K.C., and Wallentin L. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur. Heart J. 28 (2007) 2858-2865